Transgene Biotek Ltd share price logo

Transgene Biotek Ltd Share Price

(526139)

Check the latest share price of Transgene Biotek Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹3.491.69%

as on 04:01PM, 12 May 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Transgene Biotek Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹3.4
    Day's Price Range
    ₹3.72
  • 52 Week's Low

    52 Week's High

    ₹3.22
    52-Week Price Range
    ₹10.84
1 Month Return-4.57 %
3 Month Return-19.86 %
1 Year Return-47.41 %
3 Year Return-0.56 %
5 Year Return+ 2.01 %
Previous Close₹3.55
Open₹3.72
Volume47.20K
Upper Circuit₹3.72
Lower Circuit₹3.38

Transgene Biotek Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹26.90 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-44.38

Return on capital employed (ROCE)

0

Industry PE ratio

100.56

Beta (LTM)

0.28

P/B Ratio

-8.95

Dividend Yield

0

PEG Ratio

-2218.75

Quarterly Earnings Growth YOY

162.96

EPS (TTM)

-0.09

Sector

Healthcare

Book Value

1.41

Technical Analysis

How to invest in Transgene Biotek Ltd

Investing in Transgene Biotek Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Transgene Biotek Ltd or 526139 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Transgene Biotek Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Transgene Biotek Ltd with just a few clicks!

Transgene Biotek Ltd Stock's Interest Amongst Investors

15%

Period May 12, 2025 to Apr 12, 2025. Change in 30 Days vs previous period

Search interest for Transgene Biotek Ltd Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Transgene Biotek Ltd Valuation

Track how the P/E of Transgene Biotek Ltd has moved over time to understand valuation trends.

Transgene Biotek Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-227.67x)

December 31, 2024

Today (-44.38x)

May 9, 2025

Industry (100.56x)

May 9, 2025

Highest (13.23x)

October 8, 2018

LowHigh

Today’s Price to Earnings Ratio: -44.38x

Transgene Biotek Ltd Financials

Get the annual and quarterly financial summary of Transgene Biotek Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'1 24Q'2 24Q'3 24Q'4 24Q'1 25
Revenue

(in ₹ Cr)

0 (0%)0 (0%)0 (20%)0 (33%)0 (0%)
Net Income

(in ₹ Cr)

-0 (0%)0 (174%)-0 (135%)-0 (29%)-1 (689%)
Net Profit Margin-540.00% (0%)400.00% (174%)-116.67% (129%)-112.50% (4%)-887.50% (689%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

47 (0%)37 (21%)32 (13%)32 (0%)
Total Liabilities

(in ₹ Cr)

42 (0%)37 (12%)39 (3%)39 (2%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

0 (0%)0 (93%)0 (900%)0 (100%)0 (0%)

Transgene Biotek Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Transgene Biotek Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
21.68%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
70.04%
0.00
Others
8.28%
0.00

Transgene Biotek Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Transgene Biotek Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA26.900.4%1.11-1NA
BUY3,475.32179.53%0.561231,244
NA43.25-0.04%0.60112
BUY10,192.8112.03%0.64119547
NA152.5240.61%0.51248

Insights on Transgene Biotek Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 0.1 Cr → 0.12 Cr (in ₹), with an average increase of 8.3% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 70.04% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 95.2% return, outperforming this stock by 142.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 180.6% return, outperforming this stock by 181.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 21.68% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, Transgene Biotek stock has moved down by -49.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 0.2 Cr → -0.71 Cr (in ₹), with an average decrease of 284.2% per quarter

About Transgene Biotek Ltd

Transgene Biotek is a public limited company incorporated in Mar.90, engaged in research and development and manufacturing of medical reagents for diagnosis of diseases. It exports nutrients to African countries, Russia, China, Malaysia and the Philippines. The company is implementing a new project at Bollaram Anrich Industrial Area costing Rs.30 crore to set up a new manufacturing facility. The plant will work on four types of products – oral delivery of proteins and peptides, DNA vaccines, fusion proteins and biotherapeutics. The project will be funded by way of preferential offer to Batterymarch Financial Management in USA and other financial institutions.

Revenue: ₹0.08Cr as on March 2025 (Q1 25)
Net Profit: ₹0.71Cr as on March 2025 (Q1 25)
Chairperson Name: K Koteswara Rao
OrganisationTransgene Biotek Ltd
IndustryHealthcare
CEOK Koteswara Rao
E-voting on sharesClick here to vote

FAQs

What is Transgene Biotek Ltd price today?

Transgene Biotek Ltd share price today stands at ₹3.49, Open: ₹3.72, Previous Close: ₹3.55, High: ₹3.72, Low: ₹3.4, 52 Week High: ₹10.84, 52 Week Low: ₹3.22.

How to Buy Transgene Biotek Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Transgene Biotek Ltd shares

What are today's traded volumes of Transgene Biotek Ltd?

Today's traded volume of Transgene Biotek Ltd(526139) is 47.20K.

What is today's market capitalisation of Transgene Biotek Ltd?

Today's market capitalisation of Transgene Biotek Ltd(526139) is ₹26.90 Cr.

What is the 52 Week High and Low Range of Transgene Biotek Ltd?

Transgene Biotek Ltd (526139)
Price
52 Week High
₹10.84
52 Week Low
₹3.22

How much percentage Transgene Biotek Ltd is down from its 52 Week High?

Transgene Biotek Ltd (526139) share price is ₹3.49. It is down -67.80% from its 52 Week High price of ₹10.84

How much percentage Transgene Biotek Ltd is up from its 52 Week low?

Transgene Biotek Ltd (526139) share price is ₹3.49. It is up 8.39% from its 52 Week Low price of ₹3.22